Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAT: HDIT + PBSCT for Systemic Sclerosis
NCT01413100Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Sep 2011
- Primary completion
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, antithymocyte globulin rabbit, mycophenolate mofetil in systemic sclerosis (SSc), sponsored by Fred Hutchinson Cancer Center. Started Sep 2011; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbitmycophenolate mofetil
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01413100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413100.